Medtide Inc. filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming that the company’s share structure remained unchanged throughout the month.

• Authorised/Issued Share Capital Medtide’s issued H-share capital stood at 141.80 million shares, each with a par value of RMB 1.00. No shares were authorised, issued, cancelled, or repurchased during the month, leaving total issued share capital unchanged at RMB 141.80 million.

• Issued Shares and Treasury Position The number of issued H shares (excluding treasury shares) was 141.80 million, with zero treasury shares outstanding. There were no movements—positive or negative—in either category during July.

• Public Float Confirmation Management certified compliance with Hong Kong Main Board Rule 13.32D(1), confirming that at least 25 % of the H-share class remained in public hands as at 31 July 2026.

• Capital Instruments The filing recorded no share options, warrants, convertible securities, or other equity-linked instruments outstanding or issued during the reporting period.

• Governance The monthly return was submitted on 5 August 2026 by Company Secretary Chan Ching.

Overall, July 2026 was characterised by a static capital base and full adherence to Hong Kong listing requirements, underscoring Medtide’s stable equity structure and regulatory compliance.